Robert Alexander
Chief Executive Officer at ALLAKOS INC.
Net worth: 2 M $ as of 31/03/2024
Profile
Dr. Robert Alexander is a Chief Executive Officer & Director at Allakos, Inc. and an Independent Director at Allena Pharmaceuticals, Inc. He is on the Board of Directors at Allakos, Inc. and Allena Pharmaceuticals, Inc. Dr. Alexander was previously employed as a Chief Executive Officer & Director by ZS Pharma, Inc., an Independent Director by Lumena Pharmaceuticals, Inc., a Managing Partner by TL Ventures LP, a Principal by Genentech, Inc., a Principal by MPM BioEquities Adviser LLC, a Principal by MPM Capital Inc, and an Executive Chairman & Chief Executive Officer by SARcode Bioscience, Inc. He also served on the board at Alta Partners Management Corp. and Sonexa Therapeutics, Inc. He received his undergraduate degree from Miami University and a doctorate degree from The University of North Carolina at Asheville.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALLAKOS, INC.
1.36% | 04/03/2024 | 1,194,076 ( 1.36% ) | 2 M $ | 31/03/2024 |
Robert Alexander active positions
| Companies | Position | Start |
|---|---|---|
| ALLAKOS INC. | Chief Executive Officer | 01/04/2017 |
Former positions of Robert Alexander
| Companies | Position | End |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 01/02/2022 |
| ZS PHARMA INC | Chief Executive Officer | 01/03/2017 |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Chief Executive Officer | 01/04/2013 |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Director/Board Member | 01/03/2013 |
| TL Ventures LP | Corporate Officer/Principal | 01/02/2006 |
Training of Robert Alexander
| Miami University | Undergraduate Degree |
| The University of North Carolina at Asheville | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ALLAKOS INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
MPM BioEquities Adviser LLC
 MPM BioEquities Adviser LLC Investment ManagersFinance Founded in 1997 by Ansbert Gadicke and Luke Evnin, MPM BioEquities Adviser LLC is a hedge fund manager located in South San Francisco, California with an additional office in Boston. The firm is a subsidiary of MPM Capital LP, a private equity firm. | Finance |
SARcode Bioscience, Inc.
SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology SARcode Bioscience, Inc., develops biopharmaceutical products. Its program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases. The company was founded by Thomas Gadek and John P. Burnier in 2006 and is headquartered in Brisbane, CA. | Health Technology |
ZS Pharma, Inc.
 ZS Pharma, Inc. Pharmaceuticals: MajorHealth Technology ZS Pharma, Inc. engages in the development of development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. It develops treatment of hyperkalemia. It also focuses on clinical development, novel technology, and clinical trials. The company was founded by Alvaro F. Guillem and Donald Jeffrey Keyser on February 5, 2008 and is headquartered in San Mateo, CA. | Health Technology |
Lumena Pharmaceuticals, Inc.
 Lumena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lumena Pharmaceuticals, Inc. developed oral therapeutics for rare liver diseases. The firm was engaged in the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, such as nonalcoholic steatohepatitis. The company was founded by Bronislava Gedulin and Michael G. Grey in January 2011 and was headquartered in San Diego, CA. | Health Technology |
| TL Ventures LP | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Sonexa Therapeutics, Inc.
 Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Alexander
